167 related articles for article (PubMed ID: 28364168)
21. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
22. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis.
Sridhar S; Rajesh C; Jishnu PV; Jayaram P; Kabekkodu SP
Breast Cancer Res Treat; 2020 Jan; 179(2):301-313. PubMed ID: 31664550
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
Tan G; Chu C; Gui X; Li J; Chen Q
Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655
[TBL] [Abstract][Full Text] [Related]
25. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
[TBL] [Abstract][Full Text] [Related]
26. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.
Simpkins SA; Hanby AM; Holliday DL; Speirs V
J Pathol; 2012 Aug; 227(4):490-8. PubMed ID: 22488553
[TBL] [Abstract][Full Text] [Related]
27. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
28. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
29. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
30. Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.
Wan G; Xiang L; Sun X; Wang X; Li H; Ge W; Cao F
Oncotarget; 2017 Jan; 8(3):5382-5391. PubMed ID: 28036271
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Role of microRNA-205 in Human Gynecological Cancer: A Meta-Analysis of Fourteen Studies.
Wu Z; Tang H; Xiong Q; Liu D; Xia T; Liang H; Ye Q
DNA Cell Biol; 2020 May; 39(5):875-889. PubMed ID: 32354230
[TBL] [Abstract][Full Text] [Related]
32. Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: a meta-analysis.
Wang Y; Zhang Y; Hu K; Qiu J; Hu Y; Zhou M; Zhang S
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32700729
[TBL] [Abstract][Full Text] [Related]
33. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
Mu Z; Wang C; Ye Z; Rossi G; Sun C; Li L; Zhu Z; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2017 Oct; 165(3):733-741. PubMed ID: 28687903
[TBL] [Abstract][Full Text] [Related]
34. Stromal cell expression of caveolin-1 predicts outcome in breast cancer.
Sloan EK; Ciocca DR; Pouliot N; Natoli A; Restall C; Henderson MA; Fanelli MA; Cuello-Carrión FD; Gago FE; Anderson RL
Am J Pathol; 2009 Jun; 174(6):2035-43. PubMed ID: 19411449
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.
Ding ZY; Li R; Zhang QJ; Wang Y; Jiang Y; Meng QY; Xi QL; Wu GH
Cancer Med; 2019 Jun; 8(6):2717-2729. PubMed ID: 30950241
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 protein expression as a prognostic biomarker of gastrointestinal tumours: A systematic review and meta-analysis.
Kamposioras K; Dinas PC; Barriuoso J; Trachana V; Dimas K
Eur J Clin Invest; 2023 Dec; 53(12):e14065. PubMed ID: 37497737
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data.
Bozovic-Spasojevic I; Zardavas D; Brohée S; Ameye L; Fumagalli D; Ades F; de Azambuja E; Bareche Y; Piccart M; Paesmans M; Sotiriou C
Clin Cancer Res; 2017 Jun; 23(11):2702-2712. PubMed ID: 28151718
[No Abstract] [Full Text] [Related]
39. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
40. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
